Exact Mass: 266.0962

Exact Mass Matches: 266.0962

Found 234 metabolites which its exact mass value is equals to given mass value 266.0962, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

8-Oxodeoxycoformycin

8-Oxodeoxycoformycin

C11H14N4O4 (266.1015)


   

Benzarone

4-(2-ethyl-1-benzofuran-3-carbonyl)phenol

C17H14O3 (266.0943)


C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents

   

Dinex

2-Cyclohexyl-4,6-dinitrophenol

C12H14N2O5 (266.0903)


   

7-Methoxy-2-methylisoflavone

7-Methoxy-2-methyl-3-phenyl-4H-chromen-4-one

C17H14O3 (266.0943)


7-Methoxy-2-methylisoflavone is found in herbs and spices. 7-Methoxy-2-methylisoflavone is isolated from Glycyrrhiza glabra (licorice). Isolated from Glycyrrhiza glabra (licorice). 7-Methoxy-2-methylisoflavone is found in tea and herbs and spices.

   

(E)-4-[5-(4-Hydroxyphenoxy)-3-penten-1-ynyl]phenol

4-{[(2Z)-5-(4-hydroxyphenyl)pent-2-en-4-yn-1-yl]oxy}phenol

C17H14O3 (266.0943)


(E)-4-[5-(4-Hydroxyphenoxy)-3-penten-1-ynyl]phenol is found in green vegetables. (E)-4-[5-(4-Hydroxyphenoxy)-3-penten-1-ynyl]phenol is produced by asparagus (Asparagus officinalis) cell cultures. Production by asparagus (Asparagus officinalis) cell cultures. (E)-4-[5-(4-Hydroxyphenoxy)-3-penten-1-ynyl]phenol is found in green vegetables.

   

1-(3-Carboxypropyl)-3,7-dimethylxanthine

4-(3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)butanoic acid

C11H14N4O4 (266.1015)


   

3-Deazaadenosine

2-{4-amino-1H-imidazo[4,5-c]pyridin-1-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C11H14N4O4 (266.1015)


   

5-(p-Methylphenyl)-5-phenylhydantoin

2,4-Imidazolidinedione, 5- (4-methylphenyl)-5-phenyl-

C16H14N2O2 (266.1055)


   

7-Deaza-2'-deoxyguanosine

2-amino-7-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,7H-pyrrolo[2,3-d]pyrimidin-4-one

C11H14N4O4 (266.1015)


   

Doxofylline

7-[(1,3-dioxolan-2-yl)methyl]-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C11H14N4O4 (266.1015)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D019141 - Respiratory System Agents > D000996 - Antitussive Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D002491 - Central Nervous System Agents Doxofylline is an orally active PDE IV inhibitor and A1AR antagonist. Doxofylline reduces inflammation in epithelial cells via inhibiting mitochondrial ROS production and amelioration of multiple cellular pathways (NLRP3-TXNIP inflammasome activation). Doxophylline can be used in studies of asthma, chronic obstructive pulmonary disease, and bronchospasm[1][2][3].

   

Dracorhodin

5-methoxy-6-methyl-2-phenyl-7H-1-benzopyran-7-one

C17H14O3 (266.0943)


   

Forodesine

7-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-4-one

C11H14N4O4 (266.1015)


   

Glucose 3-hydroxybutyrate

2,4,5,6-tetrahydroxy-1-oxohexan-3-yl 2-hydroxybutanoate

C10H18O8 (266.1002)


   

Glucose butyrate

2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl butanoate

C10H18O8 (266.1002)


   

N-(3-Methyl-2-pyridyl)-3-phenylsuccinimide

1-(3-methylpyridin-2-yl)-3-phenylpyrrolidine-2,5-dione

C16H14N2O2 (266.1055)


   

Miroprofen

4-Imidazo(1,2-a)pyridin-2-yl-alpha-methylbenzeneacetic acid

C16H14N2O2 (266.1055)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

N-(4-Aminobenzoyl)-L-glutamic acid

2-[(4-aminophenyl)formamido]pentanedioic acid

C12H14N2O5 (266.0903)


   

2,2-Dimethylpropanal 2,4-dinitrophenylhydrazone

1-(2,2-dimethylpropylidene)-2-(2,4-dinitrophenyl)hydrazine

C11H14N4O4 (266.1015)


   

(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid

2-{[hydroxy(5-hydroxy-3,4-dihydro-2H-pyrrol-2-yl)methylidene]amino}-3-(4H-imidazol-4-yl)propanoate

C11H14N4O4 (266.1015)


   

[(2R,3S,4R,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl] 3-hydroxybutanoate

[(2R,3S,4R,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl] 3-hydroxybutanoic acid

C10H18O8 (266.1002)


   

tubercidin

2-{4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C11H14N4O4 (266.1015)


   

Tyrphostin AG 1296

6,7-Dimethoxy-2-phenylquinoxaline

C16H14N2O2 (266.1055)


   

5-Methyl-7-methoxyisoflavone

4H-1-Benzopyran-4-one, 7-methoxy-5-methyl-3-phenyl-

C17H14O3 (266.0943)


5-Methyl-7-methoxyisoflavone is a sensational, non-steroidal anabolic isoflavone. 5-Methyl-7-methoxyisoflavone shows potency increasing muscle mass and endurance[1]. 5-Methyl-7-methoxyisoflavone is a sensational, non-steroidal anabolic isoflavone. 5-Methyl-7-methoxyisoflavone shows potency increasing muscle mass and endurance[1].

   

7-Deazadenosine

7-Deazadenosine

C11H14N4O4 (266.1015)


   

Microperfuranone

Microperfuranone

C17H14O3 (266.0943)


   
   

Xenofuranone B

(+)-Xenofuranone B

C17H14O3 (266.0943)


   

3-(hydroxymethyl)-5-(6-hydroxy-9h-purin-9-yl)cyclopentane-1,2-diol

3-(hydroxymethyl)-5-(6-hydroxy-9h-purin-9-yl)cyclopentane-1,2-diol

C11H14N4O4 (266.1015)


   

7-Methoxy-2-methylisoflavone

7-Methoxy-2-methylisoflavone

C17H14O3 (266.0943)


   

2,6-Bis[(2-hydroxyethyl)amino]-3-nitrobenzonitrile

2,6-Bis[(2-hydroxyethyl)amino]-3-nitrobenzonitrile

C11H14N4O4 (266.1015)


   

URB754

6-methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one

C16H14N2O2 (266.1055)


   

1-(3-Carboxypropyl)-3,7-dimethylxanthine

1-(3-Carboxypropyl)-3,7-dimethylxanthine

C11H14N4O4 (266.1015)


CONFIDENCE standard compound; INTERNAL_ID 2785 INTERNAL_ID 2785; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 8711

   
   

N-(4-Aminobenzoyl)-DL-glutamic acid

2-[(4-aminobenzoyl)amino]pentanedioic acid

C12H14N2O5 (266.0903)


   
   

9-Deazaadenosine

9-Deazaadenosine

C11H14N4O4 (266.1015)


   

Ac-4-Hydroxychalcone

Ac-4-Hydroxychalcone

C17H14O3 (266.0943)


   

1,6-Di-Ac-Galactitol

1,6-Di-Ac-Galactitol

C10H18O8 (266.1002)


   

2,5-dihydroxy-3,6-bis(3-methylbut-3-en-1-ynyl)benzaldehyde|sterehirsutinal

2,5-dihydroxy-3,6-bis(3-methylbut-3-en-1-ynyl)benzaldehyde|sterehirsutinal

C17H14O3 (266.0943)


   
   

(Butan-2,3-diol)-D(?)-glucuronid|-D(?)-glucuronid

(Butan-2,3-diol)-D(?)-glucuronid|-D(?)-glucuronid

C10H18O8 (266.1002)


   

Acromelic acid C

Acromelic acid C

C12H14N2O5 (266.0903)


   

6-hydroxy-2-phenethyl-4H-chromen-4-one

6-hydroxy-2-phenethyl-4H-chromen-4-one

C17H14O3 (266.0943)


   

2,3-Bis(4-hydroxyphenyl)cyclopent-2-en-1-one

2,3-Bis(4-hydroxyphenyl)cyclopent-2-en-1-one

C17H14O3 (266.0943)


   

dracorhodin

7H-1-Benzopyran-7-one, 5-methoxy-6-methyl-2-phenyl-

C17H14O3 (266.0943)


Dracorhodin is a natural product found in Calamus draco with data available.

   

brosimacutin J

brosimacutin J

C17H14O3 (266.0943)


   

(Z)-3,4,4-trihydroxy-1,5-diphenylpent-3-en-1-yn|lawsochylin B

(Z)-3,4,4-trihydroxy-1,5-diphenylpent-3-en-1-yn|lawsochylin B

C17H14O3 (266.0943)


   

SCHEMBL22655389

SCHEMBL22655389

C17H14O3 (266.0943)


   

2-(4-Methoxyphenyl)-6-methyl-4H-chromen-4-one

2-(4-Methoxyphenyl)-6-methyl-4H-chromen-4-one

C17H14O3 (266.0943)


   

CHEMBL4514447

CHEMBL4514447

C17H14O3 (266.0943)


   

1,5-Bis-(4-hydroxyphenyl)-1,4-pentadien-3-one

1,5-Bis-(4-hydroxyphenyl)-1,4-pentadien-3-one

C17H14O3 (266.0943)


   

SCHEMBL16972870

SCHEMBL16972870

C17H14O3 (266.0943)


   

2-(2-4-hydroxyphenylethyl)chromone

2-(2-4-hydroxyphenylethyl)chromone

C17H14O3 (266.0943)


   
   

2-Phenethyl-7-hydroxychromone

2-Phenethyl-7-hydroxychromone

C17H14O3 (266.0943)


   
   
   

SCHEMBL745320

SCHEMBL745320

C17H14O3 (266.0943)


   

trachycladine B

trachycladine B

C11H14N4O4 (266.1015)


   

beta-Methyl-crotonsaeure-(5-benzoyl-penta-2,4-diin-yl-ester)|beta-Methyl-crotonsaeure-<5-benzoyl-penta-2,4-diin-yl-ester>

beta-Methyl-crotonsaeure-(5-benzoyl-penta-2,4-diin-yl-ester)|beta-Methyl-crotonsaeure-<5-benzoyl-penta-2,4-diin-yl-ester>

C17H14O3 (266.0943)


   

1-(3,4-dihydroxyphenyl)-5-(4-hydroxyphenyl)pent-1-en-4-yne

1-(3,4-dihydroxyphenyl)-5-(4-hydroxyphenyl)pent-1-en-4-yne

C17H14O3 (266.0943)


   

CHEMBL479683

CHEMBL479683

C17H14O3 (266.0943)


   

Tyrphostin AG 1296

6,7-Dimethoxy-2-phenylquinoxaline

C16H14N2O2 (266.1055)


D000970 - Antineoplastic Agents > D020032 - Tyrphostins

   

RG-13022

αZ-[(3,4-dimethoxyphenyl)methylene]-3-pyridineacetonitrile

C16H14N2O2 (266.1055)


D000970 - Antineoplastic Agents > D020032 - Tyrphostins

   

methoxyvone

methoxyvone

C17H14O3 (266.0943)


   

2-Phenethyl-6-hydroxychromone

6-hydroxy-2-(2-phenylethyl)chromen-4-one

C17H14O3 (266.0943)


2-Phenethyl-6-hydroxychromone is a natural product found in Aquilaria sinensis with data available.

   

Z-Asn-OH

Carbobenzoxy-L-asparagine

C12H14N2O5 (266.0903)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.482 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.481 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.477 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.480

   

4,6-Dimethyl-3(4-hydroxyphenyl)coumarin

4,6-Dimethyl-3(4-hydroxyphenyl)coumarin

C17H14O3 (266.0943)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.142 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.141 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.139

   

10-Methoxycarbamazepine

10-Methoxycarbamazepine

C16H14N2O2 (266.1055)


   

Aminobenzoyl-glutamate

Aminobenzoyl-glutamate

C12H14N2O5 (266.0903)


Annotation level-2

   

5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-ethylbarbituric acid

5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-ethylbarbituric acid

C12H14N2O5 (266.0903)


   

AG-1296

6,7-dimethoxy-2-phenyl-quinoxaline

C16H14N2O2 (266.1055)


   

(E)-4-[5-(4-Hydroxyphenoxy)-3-penten-1-ynyl]phenol

4-[(3Z)-5-(4-hydroxyphenoxy)pent-3-en-1-yn-1-yl]phenol

C17H14O3 (266.0943)


   

2E-decenoic acid 10-phosphate

10-hydroxy-2E-decenoic acid O-dihydrogen phosphate

C10H19O6P (266.0919)


   

4H-1-Benzopyran-4-one,7-hydroxy-2-(4-methoxyphenyl)-

4H-1-Benzopyran-4-one,7-hydroxy-2-(4-methoxyphenyl)-

C17H14O3 (266.0943)


   

2-[butyl[4-(2,2-dicyanovinyl)-3-methylphenyl]amino]ethyl (3,4-dichlorophenyl)carbamate

2-[butyl[4-(2,2-dicyanovinyl)-3-methylphenyl]amino]ethyl (3,4-dichlorophenyl)carbamate

C12H14N2O5 (266.0903)


   

Oxythiamine

Oxythiamine

C12H16N3O2S+ (266.0963)


D009676 - Noxae > D000963 - Antimetabolites

   

BENZOFURAN-2-CARBOXYLIC AXID (4-AMINO-2-METHYL-PHENYL)-AMINE

BENZOFURAN-2-CARBOXYLIC AXID (4-AMINO-2-METHYL-PHENYL)-AMINE

C16H14N2O2 (266.1055)


   

7-Deaza-2-deoxyguanosine

2-amino-7-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrrolo[2,3-d]pyrimidin-4-one

C11H14N4O4 (266.1015)


   

Phenol,4-amino-2-[(diethylamino)methyl]-, hydrochloride (1:2)

Phenol,4-amino-2-[(diethylamino)methyl]-, hydrochloride (1:2)

C11H20Cl2N2O (266.0953)


   

2-PHENYL-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER

2-PHENYL-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER

C16H14N2O2 (266.1055)


   

(+)-(1-Oxyl-2,2,5,5-tetramethylpyrrolidin-3-yl)methyl Methanethiosulfonate

(+)-(1-Oxyl-2,2,5,5-tetramethylpyrrolidin-3-yl)methyl Methanethiosulfonate

C10H20NO3S2 (266.0885)


   

(2-P-TOLYL-IMIDAZO[1,2-A]PYRIDIN-3-YL)-ACETIC ACID

(2-P-TOLYL-IMIDAZO[1,2-A]PYRIDIN-3-YL)-ACETIC ACID

C16H14N2O2 (266.1055)


   
   

furaprofen

furaprofen

C17H14O3 (266.0943)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

5-benzyl-5-phenylimidazolidine-2,4-dione

5-benzyl-5-phenylimidazolidine-2,4-dione

C16H14N2O2 (266.1055)


   

1H-Purine-8-butanoicacid, 2,3,6,9-tetrahydro-1,3-dimethyl-2,6-dioxo-

1H-Purine-8-butanoicacid, 2,3,6,9-tetrahydro-1,3-dimethyl-2,6-dioxo-

C11H14N4O4 (266.1015)


   

1,3-DIPHENYL-5-METHYLTHIO-1H-PYRAZOLE

1,3-DIPHENYL-5-METHYLTHIO-1H-PYRAZOLE

C16H14N2S (266.0878)


   

3-(3,5-dimethylphenyl)-4-hydroxychromen-2-one

3-(3,5-dimethylphenyl)-4-hydroxychromen-2-one

C17H14O3 (266.0943)


   

2-MERCAPTOBENZOTHIAZOLE CYCLOHEXYLAMINE SALT

2-MERCAPTOBENZOTHIAZOLE CYCLOHEXYLAMINE SALT

C13H18N2S2 (266.0911)


   
   

5-PROPYNYL-2-DEOXYURIDINE

5-PROPYNYL-2-DEOXYURIDINE

C12H14N2O5 (266.0903)


   

2-(3-METHYL-1,2,4-OXADIAZOL-5-YL)ETHANAMINE HYDROCHLORIDE

2-(3-METHYL-1,2,4-OXADIAZOL-5-YL)ETHANAMINE HYDROCHLORIDE

C16H14N2O2 (266.1055)


   

4-(Benzyloxy)-1H-indole-7-carboxamide

4-(Benzyloxy)-1H-indole-7-carboxamide

C16H14N2O2 (266.1055)


   

N*1*-BENZYL-4-TRIFLUOROMETHYL-BENZENE-1,2-DIAMINE

N*1*-BENZYL-4-TRIFLUOROMETHYL-BENZENE-1,2-DIAMINE

C14H13F3N2 (266.1031)


   
   

methyl 4-(3-oxo-3-phenyl-1-propenyl) benzoate

methyl 4-(3-oxo-3-phenyl-1-propenyl) benzoate

C17H14O3 (266.0943)


   

N,N-diisopropylbenzothiazole-2-sulphenamide

N,N-diisopropylbenzothiazole-2-sulphenamide

C13H18N2S2 (266.0911)


   

1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride

1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride

C11H20Cl2N2O (266.0953)


   

4-(2-Naphthalenethio)-1,2-phenylenediamine

4-(2-Naphthalenethio)-1,2-phenylenediamine

C16H14N2S (266.0878)


   

4-(Pyrrolidin-1-yl)-8-(trifluoromethyl)quinoline

4-(Pyrrolidin-1-yl)-8-(trifluoromethyl)quinoline

C14H13F3N2 (266.1031)


   

2-methylidene-4-oxo-4-(4-phenylphenyl)butanoic acid

2-methylidene-4-oxo-4-(4-phenylphenyl)butanoic acid

C17H14O3 (266.0943)


   

isovaleraldehyde 2,4-dinitrophenylhydrazone

isovaleraldehyde 2,4-dinitrophenylhydrazone

C11H14N4O4 (266.1015)


   

Serotonin hydrogenoxalate

Serotonin hydrogenoxalate

C12H14N2O5 (266.0903)


   

H-Glu(4-Abz-OH)-OH

H-Glu(4-Abz-OH)-OH

C12H14N2O5 (266.0903)


   

[3-[(4-cyanophenyl)carbamoyl]phenyl]boronic acid

[3-[(4-cyanophenyl)carbamoyl]phenyl]boronic acid

C14H11BN2O3 (266.0863)


   

ethyl 1-(2,4-difluorophenyl)-5-methylpyrazole-4-carboxylate

ethyl 1-(2,4-difluorophenyl)-5-methylpyrazole-4-carboxylate

C13H12F2N2O2 (266.0867)


   

ETHYL2-PHENYLIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE

ETHYL2-PHENYLIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE

C16H14N2O2 (266.1055)


   

N-(4-aminobenzoyl)-L-glutamic acid

N-(4-aminobenzoyl)-L-glutamic acid

C12H14N2O5 (266.0903)


   

tubercidin

7-Deazaadenosine(Tubercidin)

C11H14N4O4 (266.1015)


An N-glycosylpyrrolopyrimidine that is adenosine in which the in the 5-membered ring that is not attached to the ribose moiety is replaced by a carbon. Tubercidin is produced in the culture broth of Streptomyces tubericidus. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Tubercidin (7-Deazaadenosine) is an antibiotic obtained from Streptomyces tubercidicus. Tubercidin inhibits the growth of Streptococcus faecalis (8043) with an IC50 of 0.02 μM[1]. Tubercidin inhibits polymerases by incorporating DNA or RNA, thereby inhibiting DNA replication, RNA and protein synthesis[2]. Tubercidin is a weak inhibitor of adenosine phosphorylase, and interferes with the phosphorylation of adenosine and AMP[1]. Tubercidin has antiviral activity[2]. Tubercidin (7-Deazaadenosine) is an antibiotic obtained from Streptomyces tubercidicus. Tubercidin inhibits the growth of Streptococcus faecalis (8043) with an IC50 of 0.02 μM[1]. Tubercidin inhibits polymerases by incorporating DNA or RNA, thereby inhibiting DNA replication, RNA and protein synthesis[2]. Tubercidin is a weak inhibitor of adenosine phosphorylase, and interferes with the phosphorylation of adenosine and AMP[1]. Tubercidin has antiviral activity[2].

   

n-valeraldehyde 2,4-dinitrophenylhydrazone

n-valeraldehyde 2,4-dinitrophenylhydrazone

C11H14N4O4 (266.1015)


   

5-[4-(4-METHOXYPHENOXY)PHENYL!-1H-PYRAZOLE

5-[4-(4-METHOXYPHENOXY)PHENYL!-1H-PYRAZOLE

C16H14N2O2 (266.1055)


   

5-ETHYL-5-(P-HYDROXY- PHENYL)BARBITURIC ACID

5-ETHYL-5-(P-HYDROXY- PHENYL)BARBITURIC ACID

C12H14N2O5 (266.0903)


   

1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purine-7-butyric acid

1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purine-7-butyric acid

C11H14N4O4 (266.1015)


   

1-PHENYL-IMIDAZO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER

1-PHENYL-IMIDAZO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER

C16H14N2O2 (266.1055)


   

N-Cbz-D-Asparagine

N-Carbobenzyloxy-D-asparagine

C12H14N2O5 (266.0903)


   

3-(p-(2H-Indazol-2-yl)phenyl)propionic acid

3-(p-(2H-Indazol-2-yl)phenyl)propionic acid

C16H14N2O2 (266.1055)


   

1H-PYRROLO[2,3-B]PYRIDINE, 4-CHLORO-1-[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]-

1H-PYRROLO[2,3-B]PYRIDINE, 4-CHLORO-1-[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]-

C13H19ClN2Si (266.1006)


   

1H-Pyrrolo[2,3-b]pyridine, 5-chloro-1-[(1,1-dimethylethyl)dimethylsilyl]-

1H-Pyrrolo[2,3-b]pyridine, 5-chloro-1-[(1,1-dimethylethyl)dimethylsilyl]-

C13H19ClN2Si (266.1006)


   

2,4-DIHYDRO-5-(4-METHOXYPHENYL)-2-PHENYL-3H-PYRAZOL-3-ONE

2,4-DIHYDRO-5-(4-METHOXYPHENYL)-2-PHENYL-3H-PYRAZOL-3-ONE

C16H14N2O2 (266.1055)


   

3-Deazaadenosine

3-Deazaadenosine

C11H14N4O4 (266.1015)


   

Ethyl 6-phenylimidazo[1,2-a]pyridine-2-carboxylate

Ethyl 6-phenylimidazo[1,2-a]pyridine-2-carboxylate

C16H14N2O2 (266.1055)


   

(S)-6-(((Allyloxy)carbonyl)amino)-2-aminohexanoic acid hydrochloride

(S)-6-(((Allyloxy)carbonyl)amino)-2-aminohexanoic acid hydrochloride

C10H19ClN2O4 (266.1033)


   

2,6-DIMETHYL-4-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-4-OL

2,6-DIMETHYL-4-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-4-OL

C15H13F3O (266.0918)


   

4H-1-Benzopyran-4-one,7-methoxy-3-methyl-2-phenyl-

4H-1-Benzopyran-4-one,7-methoxy-3-methyl-2-phenyl-

C17H14O3 (266.0943)


   

3-(2-NITRO-1-PHENYL-ETHYL)-1H-INDOLE

3-(2-NITRO-1-PHENYL-ETHYL)-1H-INDOLE

C16H14N2O2 (266.1055)


   

4-amino-N-(2,6-dimethylphenyl)phthalimide

4-amino-N-(2,6-dimethylphenyl)phthalimide

C16H14N2O2 (266.1055)


   

Forodesine

Forodesine

C11H14N4O4 (266.1015)


C471 - Enzyme Inhibitor > C2151 - Purine Nucleoside Phosphorylase Inhibitor

   

ethyl 5-phenyl-1H-pyrrolo[2,3-c]pyridine-2-carboxylate

ethyl 5-phenyl-1H-pyrrolo[2,3-c]pyridine-2-carboxylate

C16H14N2O2 (266.1055)


   

9H-Purine, 6-methyl-9-b-D-ribofuranosyl-

9H-Purine, 6-methyl-9-b-D-ribofuranosyl-

C11H14N4O4 (266.1015)


6-Methylpurine riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

1-[4-(Benzyloxy)-1H-indazol-1-yl]ethanone

1-[4-(Benzyloxy)-1H-indazol-1-yl]ethanone

C16H14N2O2 (266.1055)


   

1,5-DIPHENYL-3-METHYLTHIO-1H-PYRAZOLE

1,5-DIPHENYL-3-METHYLTHIO-1H-PYRAZOLE

C16H14N2S (266.0878)


   

N-(3-Cyanophenyl)-4-ethoxybenzamide

N-(3-Cyanophenyl)-4-ethoxybenzamide

C16H14N2O2 (266.1055)


   

1,3-Dibenzoylacetone

1,3-Dibenzoylacetone

C17H14O3 (266.0943)


   

N-[(Benzyloxy)carbonyl]glycylglycine

N-[(Benzyloxy)carbonyl]glycylglycine

C12H14N2O5 (266.0903)


   

1,4-Bis(methylamino)-9,10-anthraquinone

1,4-Bis(methylamino)-9,10-anthraquinone

C16H14N2O2 (266.1055)


   

3-PHENYLMETHYL-3,4-DIHYDRO-1,4-BENZODIAZEPIN-2,5-DIONE

3-PHENYLMETHYL-3,4-DIHYDRO-1,4-BENZODIAZEPIN-2,5-DIONE

C16H14N2O2 (266.1055)


   

4-Chloro-2-forMylphenylboronic acid, pinacol ester

4-Chloro-2-forMylphenylboronic acid, pinacol ester

C13H16BClO3 (266.0881)


   

3,5-bis(ethoxycarbonyl)phenylboronic acid

3,5-bis(ethoxycarbonyl)phenylboronic acid

C12H15BO6 (266.0962)


   

Methyl 4-Morpholino-2-nitrobenzoate

Methyl 4-Morpholino-2-nitrobenzoate

C12H14N2O5 (266.0903)


   

9-(2-C-Methyl-β-D-ribofuranosyl)purine

9-(2-C-Methyl-β-D-ribofuranosyl)purine

C11H14N4O4 (266.1015)


   

Anthracene-9,10-diboronic acid

Anthracene-9,10-diboronic acid

C14H12B2O4 (266.0922)


   

4-methoxy-6-(5-phenyl-1,2-dihydropyrazol-3-ylidene)cyclohexa-2,4-dien-1-one

4-methoxy-6-(5-phenyl-1,2-dihydropyrazol-3-ylidene)cyclohexa-2,4-dien-1-one

C16H14N2O2 (266.1055)


   

tetrakis(dimethylamino)zirconium

tetrakis(dimethylamino)zirconium

C8H24N4Zr (266.1048)


   

4-(1,3-benzodioxol-5-yl)-2,3-dihydro-1H-1,5-benzodiazepine

4-(1,3-benzodioxol-5-yl)-2,3-dihydro-1H-1,5-benzodiazepine

C16H14N2O2 (266.1055)


   

4,6-diphenyl-3,4-dihydro-1H-pyrimidine-2-thione

4,6-diphenyl-3,4-dihydro-1H-pyrimidine-2-thione

C16H14N2S (266.0878)


KKII5 is a potent Lipoxygenase (LOX-1) inhibitor with an IC50 of 19 μM. KKII5 inhibits lipid peroxidation[1].

   

METHYL 5-MORPHOLINO-2-NITROBENZOATE

METHYL 5-MORPHOLINO-2-NITROBENZOATE

C12H14N2O5 (266.0903)


   

2-(4-METHOXY-PHENYL)-6-METHYL-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE

2-(4-METHOXY-PHENYL)-6-METHYL-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE

C16H14N2O2 (266.1055)


   

N-(4-CARBETHOXYPHENYL)-N-(3-CYANOPHENYL)AMINE

N-(4-CARBETHOXYPHENYL)-N-(3-CYANOPHENYL)AMINE

C16H14N2O2 (266.1055)


   

1-ethyl-2-naphthalen-1-ylimidazole-4-carboxylic acid

1-ethyl-2-naphthalen-1-ylimidazole-4-carboxylic acid

C16H14N2O2 (266.1055)


   

3-ethyl-2-naphthalen-1-ylimidazole-4-carboxylic acid

3-ethyl-2-naphthalen-1-ylimidazole-4-carboxylic acid

C16H14N2O2 (266.1055)


   

N-Methyl-4-[5-(trifluoromethyl)pyridin-2-yl]benzylamine

N-Methyl-4-[5-(trifluoromethyl)pyridin-2-yl]benzylamine

C14H13F3N2 (266.1031)


   

2-Methoxy-2,4-diphenyl-3(2H)-furanone

2-Methoxy-2,4-diphenyl-3(2H)-furanone

C17H14O3 (266.0943)


   

2H-1-Benzopyran-2-one,7-hydroxy-4-methyl-3-(phenylmethyl)-

2H-1-Benzopyran-2-one,7-hydroxy-4-methyl-3-(phenylmethyl)-

C17H14O3 (266.0943)


   

1-(3-Fluoro-4-methoxyphenyl)-4-oxocyclohexanecarboxylic acid

1-(3-Fluoro-4-methoxyphenyl)-4-oxocyclohexanecarboxylic acid

C14H15FO4 (266.0954)


   

1-Deaza-adenosine

1-Deaza-adenosine

C11H14N4O4 (266.1015)


   

Immucillins, 17

Immucillins, 17

C11H14N4O4 (266.1015)


   

2,2-Dimethylpropanal 2,4-dinitrophenylhydrazone

2,2-Dimethylpropanal 2,4-dinitrophenylhydrazone

C11H14N4O4 (266.1015)


   

4-{5-[(1E)-prop-1-en-1-yl]-1-benzofuran-2-yl}benzene-1,3-diol

4-{5-[(1E)-prop-1-en-1-yl]-1-benzofuran-2-yl}benzene-1,3-diol

C17H14O3 (266.0943)


   

methyl (3-phenyl-1H-indazol-1-yl)acetate

methyl (3-phenyl-1H-indazol-1-yl)acetate

C16H14N2O2 (266.1055)


   

5-(4-methylphenyl)-1-phenyl-1H-imidazole-2-thiol

5-(4-methylphenyl)-1-phenyl-1H-imidazole-2-thiol

C16H14N2S (266.0878)


   

Pyroglutamylhistidine

Pyroglutamylhistidine

C11H14N4O4 (266.1015)


   

3-(4-Hydroxyphenyl)-4,6-dimethylchromen-2-one

3-(4-Hydroxyphenyl)-4,6-dimethylchromen-2-one

C17H14O3 (266.0943)


   

Ethyl trimethylsilyl phthalate

Ethyl trimethylsilyl phthalate

C13H18O4Si (266.0974)


   

1-Diethoxyphosphinyl-4-hydroxy-2,5-hexanedione

1-Diethoxyphosphinyl-4-hydroxy-2,5-hexanedione

C10H19O6P (266.0919)


   

2-Phenethyl-2,3-dihydro-phthalazine-1,4-dione

2-Phenethyl-2,3-dihydro-phthalazine-1,4-dione

C16H14N2O2 (266.1055)


   

7-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one

7-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one

C11H14N4O4 (266.1015)


   

Doxofylline

Doxofylline

C11H14N4O4 (266.1015)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D019141 - Respiratory System Agents > D000996 - Antitussive Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D002491 - Central Nervous System Agents Doxofylline is an orally active PDE IV inhibitor and A1AR antagonist. Doxofylline reduces inflammation in epithelial cells via inhibiting mitochondrial ROS production and amelioration of multiple cellular pathways (NLRP3-TXNIP inflammasome activation). Doxophylline can be used in studies of asthma, chronic obstructive pulmonary disease, and bronchospasm[1][2][3].

   

AIDS-130588

7-Methoxy-2-methyl-3-phenyl-4H-chromen-4-one

C17H14O3 (266.0943)


   

6-Hydroxy-2-(2-phenylethyl)chromone

6-hydroxy-2-(2-phenylethyl)chromen-4-one

C17H14O3 (266.0943)


   

(-)-Microperfuranone

(-)-Microperfuranone

C17H14O3 (266.0943)


A butenolide that is furan-2(5H)-one which is substituted by a phenyl group at position 3, a benzyl group at position 4, and a hydroxy group at position 5 (the (-)-enantiomer). A secondary metabolite obtained from Aspergillus nidulans.

   

3-Benzyl-3,6-dihydroxy-6-(hydroxymethyl)-diketopiperazine

3-Benzyl-3,6-dihydroxy-6-(hydroxymethyl)-diketopiperazine

C12H14N2O5 (266.0903)


   

(2S,3R,4S,5R)-2-(5-hydroxy-1,3-benzodiazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2S,3R,4S,5R)-2-(5-hydroxy-1,3-benzodiazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C12H14N2O5 (266.0903)


   

[2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] butanoate

[2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] butanoate

C10H18O8 (266.1002)


   

(2,4,5,6-Tetrahydroxy-1-oxohexan-3-yl) 2-hydroxybutanoate

(2,4,5,6-Tetrahydroxy-1-oxohexan-3-yl) 2-hydroxybutanoate

C10H18O8 (266.1002)


   

[(2R,3S,4R,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl] 3-hydroxybutanoate

[(2R,3S,4R,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl] 3-hydroxybutanoate

C10H18O8 (266.1002)


   

3-(4H-imidazol-4-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoic acid

3-(4H-imidazol-4-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoic acid

C11H14N4O4 (266.1015)


   

5-[(4-Methylphenoxy)methyl]-3-phenyl-1,2,4-oxadiazole

5-[(4-Methylphenoxy)methyl]-3-phenyl-1,2,4-oxadiazole

C16H14N2O2 (266.1055)


   

3-(4-Methoxyphenyl)-5-(4-methylphenyl)-1,2,4-oxadiazole

3-(4-Methoxyphenyl)-5-(4-methylphenyl)-1,2,4-oxadiazole

C16H14N2O2 (266.1055)


   

6-(4-ethoxy-1H-quinazolin-2-ylidene)-1-cyclohexa-2,4-dienone

6-(4-ethoxy-1H-quinazolin-2-ylidene)-1-cyclohexa-2,4-dienone

C16H14N2O2 (266.1055)


   
   

4-Methoxy-2-(4-methoxyphenyl)quinazoline

4-Methoxy-2-(4-methoxyphenyl)quinazoline

C16H14N2O2 (266.1055)


   

2-(1,2-benzoxazol-3-yl)-N-(3-methylphenyl)acetamide

2-(1,2-benzoxazol-3-yl)-N-(3-methylphenyl)acetamide

C16H14N2O2 (266.1055)


   

(2S,3R,4R,4aS,5S,6R,7S,8aR)-6-methylhexahydro-2H-1-benzopyran-2,3,4,4a,5,6,7(5H)-heptol

(2S,3R,4R,4aS,5S,6R,7S,8aR)-6-methylhexahydro-2H-1-benzopyran-2,3,4,4a,5,6,7(5H)-heptol

C10H18O8 (266.1002)


   

1-methyl-1-(oxidoamino)-3-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea

1-methyl-1-(oxidoamino)-3-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea

C8H16N3O7- (266.0988)


   

1-Methyl-1-(oxidoamino)-3-[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea

1-Methyl-1-(oxidoamino)-3-[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea

C8H16N3O7- (266.0988)


   

1-methyl-1-(oxidoamino)-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea

1-methyl-1-(oxidoamino)-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea

C8H16N3O7- (266.0988)


   

4-(oxidoamino)-2,5-diphenyl-1H-pyrazol-3-one

4-(oxidoamino)-2,5-diphenyl-1H-pyrazol-3-one

C15H12N3O2- (266.0929)


   

4-Hydroxy-6,8-dimethylflavone

4-Hydroxy-6,8-dimethylflavone

C17H14O3 (266.0943)


   

CID 134769419

CID 134769419

C10H26Sn (266.1056)


   

Benzarone

2-Ethyl-3-(4-hydroxybenzoyl)benzofuran

C17H14O3 (266.0943)


C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents

   

7-Methoxy-2-methyl-3-phenyl-4H-chromen-4-one

7-Methoxy-2-methyl-3-phenyl-4H-chromen-4-one

C17H14O3 (266.0943)


   

Miroprofen

Miroprofen

C16H14N2O2 (266.1055)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

2-(2,4-dihydroxyphenyl)-5-(E)-propenylbenzofuran

2-(2,4-dihydroxyphenyl)-5-(E)-propenylbenzofuran

C17H14O3 (266.0943)


A member of the class of benzofurans that is 1-benzofuran substituted by a 2,4-dihydroxyphenyl group at position 2 and a prop-1-en-1-yl group at position 5. It is a lignan derivative isolated from the roots of Krameria lappacea.

   

dehydrodeoxycoformycin

dehydrodeoxycoformycin

C11H14N4O4 (266.1015)


A coformycin that is dehydrocoformycin with the hydroxy group at position 2 replaced with a hydrogen.

   

Oxodeoxycoformycin

Oxodeoxycoformycin

C11H14N4O4 (266.1015)


   

4-Aminobenzoylglutamic acid

4-Aminobenzoylglutamic acid

C12H14N2O5 (266.0903)


   

Aminobenzoylglutamic acid

Aminobenzoylglutamic acid

C12H14N2O5 (266.0903)


   
   

(5s)-4-benzyl-5-hydroxy-3-phenyl-5h-furan-2-one

(5s)-4-benzyl-5-hydroxy-3-phenyl-5h-furan-2-one

C17H14O3 (266.0943)


   

10-methoxy-6h,7h,12h-indolo[2,3-a]quinolizin-4-one

10-methoxy-6h,7h,12h-indolo[2,3-a]quinolizin-4-one

C16H14N2O2 (266.1055)


   

8-hydroxy-3-(2-phenylethenyl)-3,4-dihydro-2-benzopyran-1-one

8-hydroxy-3-(2-phenylethenyl)-3,4-dihydro-2-benzopyran-1-one

C17H14O3 (266.0943)


   

(2s,3s,4s)-3-(carboxymethyl)-4-(6-hydroxypyridin-3-yl)pyrrolidine-2-carboxylic acid

(2s,3s,4s)-3-(carboxymethyl)-4-(6-hydroxypyridin-3-yl)pyrrolidine-2-carboxylic acid

C12H14N2O5 (266.0903)


   

4-[(3e)-5-(4-hydroxyphenoxy)pent-3-en-1-yn-1-yl]phenol

4-[(3e)-5-(4-hydroxyphenoxy)pent-3-en-1-yn-1-yl]phenol

C17H14O3 (266.0943)


   

asparenydiol

NA

C17H14O3 (266.0943)


{"Ingredient_id": "HBIN017122","Ingredient_name": "asparenydiol","Alias": "NA","Ingredient_formula": "C17H14O3","Ingredient_Smile": "C1=CC(=CC=C1C#CC=CCOC2=CC=C(C=C2)O)O","Ingredient_weight": "266.29 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1885","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10084256","DrugBank_id": "NA"}

   

3-[hydroxy(phenyl)methyl]-4-phenyl-5h-furan-2-one

3-[hydroxy(phenyl)methyl]-4-phenyl-5h-furan-2-one

C17H14O3 (266.0943)


   

5-hydroxy-2-(2-phenylethyl)chromen-4-one

5-hydroxy-2-(2-phenylethyl)chromen-4-one

C17H14O3 (266.0943)


   

5-benzyl-3-hydroxy-4-phenyl-5h-furan-2-one

5-benzyl-3-hydroxy-4-phenyl-5h-furan-2-one

C17H14O3 (266.0943)


   

4-[(1e)-5-(4-hydroxyphenyl)pent-1-en-4-yn-1-yl]benzene-1,2-diol

4-[(1e)-5-(4-hydroxyphenyl)pent-1-en-4-yn-1-yl]benzene-1,2-diol

C17H14O3 (266.0943)


   

2-(6-hydroxypurin-9-yl)-3,5-dimethyloxolane-3,4-diol

2-(6-hydroxypurin-9-yl)-3,5-dimethyloxolane-3,4-diol

C11H14N4O4 (266.1015)


   

(2r,3r,4r,5r)-2-(6-hydroxypurin-9-yl)-3,5-dimethyloxolane-3,4-diol

(2r,3r,4r,5r)-2-(6-hydroxypurin-9-yl)-3,5-dimethyloxolane-3,4-diol

C11H14N4O4 (266.1015)


   

3-(carboxymethyl)-4-(6-hydroxypyridin-3-yl)pyrrolidine-2-carboxylic acid

3-(carboxymethyl)-4-(6-hydroxypyridin-3-yl)pyrrolidine-2-carboxylic acid

C12H14N2O5 (266.0903)


   

2-(hydroxymethyl)-5-{4-imino-3h,5h-pyrrolo[3,2-d]pyrimidin-7-yl}oxolane-3,4-diol

2-(hydroxymethyl)-5-{4-imino-3h,5h-pyrrolo[3,2-d]pyrimidin-7-yl}oxolane-3,4-diol

C11H14N4O4 (266.1015)


   

2,5-dihydroxy-3,6-bis(3-methylbut-3-en-1-yn-1-yl)benzaldehyde

2,5-dihydroxy-3,6-bis(3-methylbut-3-en-1-yn-1-yl)benzaldehyde

C17H14O3 (266.0943)


   

4-[5-(prop-1-en-1-yl)-1-benzofuran-2-yl]benzene-1,3-diol

4-[5-(prop-1-en-1-yl)-1-benzofuran-2-yl]benzene-1,3-diol

C17H14O3 (266.0943)


   

7-hydroxy-2-(2-phenylethyl)chromen-4-one

7-hydroxy-2-(2-phenylethyl)chromen-4-one

C17H14O3 (266.0943)


   

4-[5-(4-hydroxyphenyl)pent-1-en-4-yn-1-yl]benzene-1,2-diol

4-[5-(4-hydroxyphenyl)pent-1-en-4-yn-1-yl]benzene-1,2-diol

C17H14O3 (266.0943)


   

(3r)-8-hydroxy-3-[(1e)-2-phenylethenyl]-3,4-dihydro-2-benzopyran-1-one

(3r)-8-hydroxy-3-[(1e)-2-phenylethenyl]-3,4-dihydro-2-benzopyran-1-one

C17H14O3 (266.0943)


   

9,10-dimethoxyanthracene-2-carbaldehyde

9,10-dimethoxyanthracene-2-carbaldehyde

C17H14O3 (266.0943)


   

6-oxo-6-phenylhexa-2,4-diyn-1-yl 3-methylbut-2-enoate

6-oxo-6-phenylhexa-2,4-diyn-1-yl 3-methylbut-2-enoate

C17H14O3 (266.0943)


   

8-hydroxy-3-[(1e)-2-phenylethenyl]-3,4-dihydro-2-benzopyran-1-one

8-hydroxy-3-[(1e)-2-phenylethenyl]-3,4-dihydro-2-benzopyran-1-one

C17H14O3 (266.0943)


   

4-[(12s)-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraen-12-yl]phenol

4-[(12s)-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraen-12-yl]phenol

C17H14O3 (266.0943)


   

(5s)-5-benzyl-3-hydroxy-4-phenyl-5h-furan-2-one

(5s)-5-benzyl-3-hydroxy-4-phenyl-5h-furan-2-one

C17H14O3 (266.0943)


   

5-hydroxy-7-methyl-2-(4-methylphenyl)chromen-4-one

5-hydroxy-7-methyl-2-(4-methylphenyl)chromen-4-one

C17H14O3 (266.0943)


   

4-{5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraen-12-yl}phenol

4-{5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraen-12-yl}phenol

C17H14O3 (266.0943)


   

4-[(4e)-5-(4-hydroxyphenyl)pent-4-en-1-yn-1-yl]benzene-1,2-diol

4-[(4e)-5-(4-hydroxyphenyl)pent-4-en-1-yn-1-yl]benzene-1,2-diol

C17H14O3 (266.0943)


   

3-(4-methoxyphenyl)-7-methylchromen-4-one

3-(4-methoxyphenyl)-7-methylchromen-4-one

C17H14O3 (266.0943)


   

(5r)-5-benzyl-3-hydroxy-4-phenyl-5h-furan-2-one

(5r)-5-benzyl-3-hydroxy-4-phenyl-5h-furan-2-one

C17H14O3 (266.0943)


   

4-[5-(4-hydroxyphenoxy)pent-3-en-1-yn-1-yl]phenol

4-[5-(4-hydroxyphenoxy)pent-3-en-1-yn-1-yl]phenol

C17H14O3 (266.0943)


   

{n'-[(2s)-1-methoxy-1-oxo-3-phenylpropan-2-yl]hydrazinecarbonyl}formic acid

{n'-[(2s)-1-methoxy-1-oxo-3-phenylpropan-2-yl]hydrazinecarbonyl}formic acid

C12H14N2O5 (266.0903)


   

1-{3-benzyl-1-hydroxypyrrolo[1,2-a]pyrazin-4-yl}ethanone

1-{3-benzyl-1-hydroxypyrrolo[1,2-a]pyrazin-4-yl}ethanone

C16H14N2O2 (266.1055)


   

3-hydroxy-5,5,13-trimethyl-4,13-diazatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-1,3,6,8,10,12(15)-hexaen-14-one

3-hydroxy-5,5,13-trimethyl-4,13-diazatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-1,3,6,8,10,12(15)-hexaen-14-one

C16H14N2O2 (266.1055)


   

(2r,3s,4r,5s)-2-(hydroxymethyl)-5-{4-imino-3h,5h-pyrrolo[3,2-d]pyrimidin-7-yl}oxolane-3,4-diol

(2r,3s,4r,5s)-2-(hydroxymethyl)-5-{4-imino-3h,5h-pyrrolo[3,2-d]pyrimidin-7-yl}oxolane-3,4-diol

C11H14N4O4 (266.1015)